ES2012167A6 - Method for stabilization of laminar hydrated lipid phases and composition of laminar hydrated lipid phases - Google Patents

Method for stabilization of laminar hydrated lipid phases and composition of laminar hydrated lipid phases

Info

Publication number
ES2012167A6
ES2012167A6 ES8803789A ES8803789A ES2012167A6 ES 2012167 A6 ES2012167 A6 ES 2012167A6 ES 8803789 A ES8803789 A ES 8803789A ES 8803789 A ES8803789 A ES 8803789A ES 2012167 A6 ES2012167 A6 ES 2012167A6
Authority
ES
Spain
Prior art keywords
laminar
lipid phases
hydrated lipid
composition
stabilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8803789A
Other languages
Spanish (es)
Inventor
Alain Huc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotetica S A
Original Assignee
Biotetica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotetica S A filed Critical Biotetica S A
Priority to ES8803789A priority Critical patent/ES2012167A6/en
Publication of ES2012167A6 publication Critical patent/ES2012167A6/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

Method for stabilization of laminar hydrated lipid phases and composition of laminar hydrated lipid phases. The invention relates to a method for stabilizing laminar hydrated lipid phases, liposomes for example. This composition contains laminar hydrated lipid phases, liposomes for example, stabilized by the presence of a stabilizing support, and is characterized in that the stabilizing support is in the form of a solution which contains a mixture of atelocollagen and glycosaminoglycans. The relative proportion is preferably from 18 to 25% by weight of glycosaminoglycans relative to atelocollagen. The preferred use of this composition is in pharmacy or cosmetics.
ES8803789A 1988-12-13 1988-12-13 Method for stabilization of laminar hydrated lipid phases and composition of laminar hydrated lipid phases Expired - Lifetime ES2012167A6 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES8803789A ES2012167A6 (en) 1988-12-13 1988-12-13 Method for stabilization of laminar hydrated lipid phases and composition of laminar hydrated lipid phases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES8803789A ES2012167A6 (en) 1988-12-13 1988-12-13 Method for stabilization of laminar hydrated lipid phases and composition of laminar hydrated lipid phases

Publications (1)

Publication Number Publication Date
ES2012167A6 true ES2012167A6 (en) 1990-03-01

Family

ID=8259368

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8803789A Expired - Lifetime ES2012167A6 (en) 1988-12-13 1988-12-13 Method for stabilization of laminar hydrated lipid phases and composition of laminar hydrated lipid phases

Country Status (1)

Country Link
ES (1) ES2012167A6 (en)

Similar Documents

Publication Publication Date Title
IL105727A (en) 7-(2-mercapto-acetamido)-octahydro-6-oxopyrido[2,1-a][2]-benzazepine derivatives analogs thereof their preparation and pharmaceutical enkephalinase-inhibiting compositions containing them
CA2094267A1 (en) Use of fatty alcohol based composition for preparing emulsions, method of preparing emulsions and emulsions so obtained
MY116535A (en) New stable pharmaceutical preparation for producing propellant gas-free aerosols
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
GR3030575T3 (en) Personal cleansing compositions
GB2189145B (en) Cosmetic composition for combating the greasy appearance of hair
NO954342L (en) Erythropoietin analog mixtures, as well as processes for their preparation
HUT65192A (en) Process for producing pyrido-, pyrrolo-, thiazino-, oxazino- and pyrazino benzazepine derivatives and pharmaceutical preparations containing
EP0275005A3 (en) Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them
MY121201A (en) Pharmaceutical emulsion.
IL102759A0 (en) Hydantoin derivatives,their preparation and pharmaceutical compositions containing them
IL104716A (en) 7-1-oxo-2- (substituted mercapto)-3- phenylpropyl) amino| octahydro-6-pyrido £2, 1-a| benzazepine- 4-carboxylic acid derivatives and analogs, their preparation and pharmaceutical compositions containing them for inhibiting enkephalinase and ace
HU9603584D0 (en) Sterol derivatives which applicable for regulation of meiosis
HU214593B (en) Cosmetic, hygienic and beauty and body care preparations and methods for their preparation
IL75637A (en) Thymopentin analogs and pharmaceutical compositions containing them
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
MX9207394A (en) STEROIDS OF 17-ESPIROFURAN-3'-ILIDENO.
PL320734A1 (en) Novel emulsifiers, their production and application of theam in production of cosmetic and pharmaceutic preparations
MY100883A (en) The use of salicylic acid esters as perfumes, perfume compositions containing them and new salicylic esters.
EP0221728A3 (en) Monosaccharide containing wound healing preparation
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
HUT55034A (en) Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
EP0447551A4 (en) Stabilization of composition containing anionic surfactant
EP0521103A4 (en) Novel cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis
GR3033112T3 (en) Stabilised sunscreen compositions

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-12-13